BTG Specialty Pharmaceuticals Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

BTG Specialty Pharmaceuticals's estimated annual revenue is currently $35M per year.(i)
BTG Specialty Pharmaceuticals's estimated revenue per employee is $201,000

Name	Title	Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Imaging Endpoin...	$53.7M	267	16%	N/A	N/A
#2 Southern Script...	$53.1M	264	21%	N/A	N/A
#3 Alfasigma USA	$69.1M	344	26%	N/A	N/A
#4 US WorldMeds	$22.1M	110	-10%	N/A	N/A
#5 PharmaCord	$151.8M	755	11%	N/A	N/A
#6 KCAS Bioanalyti...	$63.9M	318	13%	N/A	N/A
#7 BioTek reMEDys	$29.9M	149	13%	N/A	N/A
#8 Endocyte	$1.7M	17	-6%	$114.3M	N/A
#9 Envision Commun...	$6.8M	34	-6%	N/A	N/A
#10 Peachtree Biore...	$12.5M	62	-9%	N/A	N/A

keywords:N/A

N/A

Total Funding

174

Number of Employees

$35M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Thomas Kolaras has been named chief commercial officer, U.S., for SERB and BTG Specialty Pharmaceuticals, the companies said Monday.

Philadelphia, April 11, 2022 (GLOBE NEWSWIRE) -- SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been...

Together, SERB and BTG Specialty Pharmaceuticals are a growing specialty pharmaceutical group and a dedicated ally to healthcare providers...

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 TicketSwap	$39.2M	174	-10%	N/A
#2 CIC biomaGUNE	$19.5M	174	14%	N/A
#3 POMPES FUNEBRES...	$19.1M	174	19%	N/A
#4 The Growth Comp...	$34.5M	174	7%	N/A
#5 United Energy T...	$46.9M	174	15%	N/A